Follow RSS for latest reports on this topicCancer - Market Research and Reports

Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs.  Cancer sometimes begins in one part of the body before spreading to other areas. This process is known as metastasis.  There are over 200 different types of cancer, each with its own methods of diagnosis and treatment.

Cancer (malignant neoplasm) is a class of disease. There are malignancy properties that cancer cells have; 

1. The diseased tissue grows uncontrollably, ignoring growth arrest signals, 

2. The cells can invade and destroy adjacent tissues

3. Cells can metastize, spreading to other regions of the body

The causes of cancer can be hereditary (5-10% of cancers) or due to environmental factors (old age, lifestyle choices, tobacco use, dietary choices, obesity, infections, radiation, lack of physical activity, and environmental pollutants). The changes in the cancer cell tip the balance of cell division and apoptosis in favor of cell division. This balance is normally maintained by oncogenes and tumor suppressor genes.

How common is cancer?

Cancer is a common condition. In 2009, 320,467 new cases of cancer were diagnosed in the UK. More than one in three people will develop some form of cancer during their lifetime.

In the UK, the most common types of cancer are:

  • breast cancer
  • prostate cancer
  • lung cancer
  • bowel cancer
  • bladder cancer
  • uterine (womb) cancer

Cancer treatment

Each specific type of cancer has its own set of treatment methods.  However, many cases of cancer are treated using chemotherapy (powerful cancer-killing medication) and radiotherapy (the controlled use of high energy X-rays). Surgery is also sometimes carried out to remove cancerous tissue.

BioPortfolio's Easy Ordering System

  1. Search for the report you need from our store
  2. Make online payment with our easy checkout process
  3. Receive PDF report via email

Easy Online Payment or Pro Forma Invoice

We accept the following credit cards...



or can supply a pro-forma invoice if required.

Related Reports:

We found over 40 reports that matched your search.

Next 40 Matches >

Refine your search, and find more matches, using the form above.

Engineered T Cells Market by Type (Tumor Infiltrating Lymphocytes, T Cell Receptor, and Chimeric Antigen Receptor), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Leukemia, and Others), and End User (Hospitals, Cancer Research Centers, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2017-2023 [Report Updated: 01-01-2018]

T cell is a type of white blood cell, and plays an important role in cell-medicated immunity. Engineered T cells are genetically modified T cells, specifically altered for therapeutic actions against autoimmune diseases and various types of cancers. The engineered T cells are delivered into patient’s body to reduce toxicity levels and restrict antigen escape (inability of immune system to respon...Read More >>>

Published:
2018-01-01

Published by: Allied Market Research

Prices Starting From:
$3840

Published:
2017-12-08

Published by: Venture Planning Group (VPG)

Prices Starting From:
$34500

Published:
2017-12-08

Published by: Venture Planning Group (VPG)

Prices Starting From:
$9800

Companion Diagnostics Market by Technology (PCR, IHC, NGS, ISH), Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) - Global Forecast to 2022 [Report Updated: 01-08-2017]

“Global companion diagnostics market projected to grow at CAGR of 20.1%”The global companion diagnostics market is projected to reach USD 6.51 billion by 2022 from USD 2.61 billion in 2017, at a CAGR of 20.1%. The growth of this market is majorly driven by the factors such as improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence across the globe, a...Read More >>>

Published:
2017-08-01

Published by: MarketsandMarkets

Prices Starting From:
$5650

Oncology Drugs Market Global Report 2017 Including: Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Non-Small Cell Lung Cancer , Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Others (Kaposi Sarcoma, Aids-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicula [Report Updated: 17-07-2017]

Oncology Drugs market covers drugs that are used in the treatment of a wide range of cancer, sarcoma, and tumor. Some of the bestselling oncology drugs in 2016 include Avastin, Herceptin, Revlimid, MabThera/Rituxan, Gleevac/Glivec, Alimta, Zytiga, Tasigna, Sandostatin, and Afinitor.


The global oncology drugs market was estimated to be around 8 billion as of 2016. The oncology drugs market market made up around 11% Read More >>>

Published:
2017-07-17

Published by: The Business Research Company

Prices Starting From:
$4000

Cancer Immunotherapy Market by Technology (Monoclonal Antibodies, Cytokines & Immunomodulators, and Others), by Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Others) by End User (Hospitals, Cancer Research Centers, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2014-2022 [Report Updated: 18-05-2017]

CHAPTER 1 INTRODUCTION1.1. REPORT DESCRIPTION1.2. KEY BENEFITS1.3. KEY MARKET SEGMENT1.4. RESEARCH METHODOLOGY1.4.1. Secondary research1.4.2. Primary research1.5. ANALYST TOOLS AND MODELSCHAPTER 2 EXECUTIVE SUMMARY2.1. KEY FINDINGS OF THE STUDY2.2. CXO PERSPECTIVECHAPTER 3 MARKET OVERVIEW3.1. MARKET DEFINITION AND SCOPE3.2. KEY FINDINGS3.2.1. Top investment pockets3.2.2. Top winning strategies3.3....Read More >>>

Published:
2017-05-18

Published by: Allied Market Research

Prices Starting From:
$5370

Published:
2017-03-30

Published by: Venture Planning Group (VPG)

Prices Starting From:
$34500

Published:
2017-03-30

Published by: Venture Planning Group (VPG)

Prices Starting From:
$9800

Cancer Biomarkers Market by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, and Cytogenetics Based Tests), Biomolecules (Genetic Biomarkers, Protein Biomarkers, and Glycoprotein Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Stomach Cancer, and Other Cancers), Application (Diagnostics, Drug Discovery and Development, Prognosti [Report Updated: 01-12-2016]

Cancer biomarkers are biomolecules that specifies the existence of cancer or cancerous cells in the body. These are generally molecules that are released due to the presence of a tumor or a particular indication in the body to the presence of cancer. These molecules are densely distributed in tissues, urine, serum, blood, and other body fluids. Their expression levels serve as the basis or indicat...Read More >>>

Published:
2016-12-01

Published by: Allied Market Research

Prices Starting From:
$5370

2016 Estonia Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers [Report Updated: 24-10-2016]

This new report from VPG Market Research provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales for major cancer diagnostics t...Read More >>>

Published:
2016-10-24

Published by: Venture Planning Group (VPG)

Prices Starting From:
$4850

2016 Greece Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers [Report Updated: 24-10-2016]

This new report from VPG Market Research provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales for major cancer diagnostics t...Read More >>>

Published:
2016-10-24

Published by: Venture Planning Group (VPG)

Prices Starting From:
$4850

2016 Latvia Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers [Report Updated: 24-10-2016]

This new report from VPG Market Research provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales for major cancer diagnostics t...Read More >>>

Published:
2016-10-24

Published by: Venture Planning Group (VPG)

Prices Starting From:
$4850

2016 Norway Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers [Report Updated: 24-10-2016]

This new report from VPG Market Research provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales for major cancer diagnostics t...Read More >>>

Published:
2016-10-24

Published by: Venture Planning Group (VPG)

Prices Starting From:
$4850

Published:
2016-09-15

Published by: MarketsandMarkets

Prices Starting From:
$5650

Published:
2016-08-02

Published by: Venture Planning Group (VPG)

Prices Starting From:
$34500

Published:
2016-08-02

Published by: Venture Planning Group (VPG)

Prices Starting From:
$9800

Published:
2016-02-25

Published by: Industry ARC

Prices Starting From:
$5250

Published:
2016-02-08

Published by: Venture Planning Group (VPG)

Prices Starting From:
$21100

Published:
2016-02-08

Published by: Venture Planning Group (VPG)

Prices Starting From:
$6400

Published:
2016-01-22

Published by: Industry ARC

Prices Starting From:
$5250

Published:
2015-12-02

Published by: MarketsandMarkets

Prices Starting From:
$5650

Companion Diagnostics Market: By Technology (PCR, Polymerase Chain Reaction (PCR), ISH, IHC, Others) Applications (Breast Cancer, Lung Cancer, Gastric Cancer, Others) End Users (Pharmaceuticals, Laboratries, Research Institutes, Others)-Forecast(2017-2022) [Report Updated: 18-07-2015]

Companion diagnostics is an in-vitro diagnostic tool that assists physicians in optimizing treatment decisions for their patients. The companion diagnostic is crucial for the safe and effective use of the drug and have been widely developed for myriad of cancer and other therapies. Each companion diagnostic test is specifically designed to be paired with a specific drug. Such tests can also save s...Read More >>>

Published:
2015-07-18

Published by: Industry ARC

Prices Starting From:
$5250

Published:
2015-06-10

Published by: MarketsandMarkets

Prices Starting From:
$5650

We Stock...

{STICKYFOOTERMOBILE}